StockTipsArenaBeta

BUY Divi's Laboratories Limited — Chandan Taparia, Motilal Oswal

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))28 Oct 2026via NDTV Profit (Live)

Entry₹9,460Inferred
Target₹9,900
Total upside +4.65%
Stop loss₹9,300-1.69% risk
CMP₹9,558.511h ago
Active+1.04%+3.57%upside left 13d left
Follow Chandan Taparia for new calls(32% target hit, 269 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 3 other Swing calls on DIVISLABSee 202 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 29 Oct, 3:42 am IST
3 supporting1 neutral1 opposing
Supports the BUY call (3)

3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·28 Oct · today

Divi's Laboratories shares in focus as weight loss drug receives EU panel backing

NewsCnbc-Tv18·19 Oct · 1w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·26 Aug · 2mo ago

Neutral / worth noting (1)

Q2 FY27 results scheduled — board meets 07 Nov 2026

BSE · Board Meeting·In 9 days

(opens in new tab)
Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·28 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Chandan Taparia, Motilal Oswal

Every call and its outcome